Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nrf1
|
ENSMUSG00000058440.8 | nuclear respiratory factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_30048253_30048874 | Nrf1 | 412 | 0.827904 | 0.79 | 5.0e-13 | Click! |
chr6_30047827_30048011 | Nrf1 | 69 | 0.970259 | 0.78 | 1.5e-12 | Click! |
chr6_30048058_30048215 | Nrf1 | 15 | 0.975086 | 0.74 | 8.3e-11 | Click! |
chr6_30047409_30047792 | Nrf1 | 388 | 0.841205 | 0.55 | 1.7e-05 | Click! |
chr6_30121712_30121863 | Nrf1 | 5672 | 0.170044 | -0.23 | 9.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_155992538_155992957 | 29.43 |
B3galt6 |
UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 |
98 |
0.52 |
chr2_153492229_153493481 | 21.70 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr18_80206481_80207497 | 20.37 |
Gm16286 |
predicted gene 16286 |
71 |
0.52 |
chr1_24005288_24006003 | 19.46 |
Sdhaf4 |
succinate dehydrogenase complex assembly factor 4 |
11 |
0.64 |
chr1_166002288_166003185 | 19.19 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr16_97962171_97962389 | 17.50 |
Zbtb21 |
zinc finger and BTB domain containing 21 |
313 |
0.48 |
chr17_75551163_75552443 | 17.40 |
Fam98a |
family with sequence similarity 98, member A |
7 |
0.99 |
chr8_70865399_70865967 | 17.22 |
Kcnn1 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 |
2425 |
0.11 |
chr4_46854768_46855398 | 16.54 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
4819 |
0.3 |
chr1_159231796_159232303 | 16.13 |
Cop1 |
COP1, E3 ubiquitin ligase |
271 |
0.89 |
chr4_141545541_141546268 | 16.08 |
B330016D10Rik |
RIKEN cDNA B330016D10 gene |
285 |
0.86 |
chr5_123057752_123058346 | 16.04 |
Gm6444 |
predicted gene 6444 |
8193 |
0.09 |
chr1_134494500_134494704 | 15.89 |
Rabif |
RAB interacting factor |
46 |
0.95 |
chr3_103171228_103172264 | 15.39 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr2_128943878_128944327 | 15.20 |
Zc3h8 |
zinc finger CCCH type containing 8 |
25 |
0.96 |
chr3_53017129_53017320 | 15.05 |
Cog6 |
component of oligomeric golgi complex 6 |
6 |
0.97 |
chr8_88138221_88138425 | 14.84 |
Mir7071 |
microRNA 7071 |
117 |
0.55 |
chr11_86544696_86545088 | 14.59 |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
87 |
0.51 |
chr18_34409280_34409507 | 14.56 |
Pkd2l2 |
polycystic kidney disease 2-like 2 |
30 |
0.98 |
chr13_74349618_74350416 | 14.27 |
Sdha |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) |
140 |
0.67 |
chr7_24399441_24399761 | 14.15 |
Smg9 |
smg-9 homolog, nonsense mediated mRNA decay factor (C. elegans) |
18 |
0.95 |
chr11_97315534_97315705 | 13.87 |
Mrpl45 |
mitochondrial ribosomal protein L45 |
97 |
0.95 |
chr5_30231959_30233086 | 13.82 |
Selenoi |
selenoprotein I |
59 |
0.96 |
chr10_77581485_77581863 | 13.68 |
Pttg1ip |
pituitary tumor-transforming 1 interacting protein |
46 |
0.95 |
chr4_46196210_46196481 | 13.47 |
Xpa |
xeroderma pigmentosum, complementation group A |
34 |
0.97 |
chr2_155956122_155956327 | 13.36 |
Cep250 |
centrosomal protein 250 |
234 |
0.87 |
chr4_8689860_8690380 | 13.27 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
286 |
0.93 |
chr10_63243576_63243947 | 13.23 |
Herc4 |
hect domain and RLD 4 |
49 |
0.85 |
chr10_71347276_71347876 | 13.19 |
Ipmk |
inositol polyphosphate multikinase |
187 |
0.92 |
chr15_103239717_103240078 | 13.00 |
Cbx5 |
chromobox 5 |
81 |
0.87 |
chr18_24121514_24121687 | 13.00 |
Ino80c |
INO80 complex subunit C |
235 |
0.94 |
chr8_4238228_4238907 | 12.97 |
Map2k7 |
mitogen-activated protein kinase kinase 7 |
173 |
0.62 |
chr8_119558350_119558658 | 12.90 |
Mbtps1 |
membrane-bound transcription factor peptidase, site 1 |
63 |
0.96 |
chr19_8716035_8716337 | 12.87 |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
1753 |
0.1 |
chr12_80778227_80778545 | 12.80 |
Gm47941 |
predicted gene, 47941 |
11957 |
0.12 |
chr11_6274706_6275544 | 12.77 |
Tmed4 |
transmembrane p24 trafficking protein 4 |
255 |
0.84 |
chr13_114818127_114818328 | 12.55 |
Mocs2 |
molybdenum cofactor synthesis 2 |
9 |
0.99 |
chr5_32458723_32459100 | 12.50 |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
68 |
0.93 |
chr13_94788681_94789006 | 12.44 |
Tbca |
tubulin cofactor A |
67 |
0.97 |
chr11_77982392_77982916 | 12.40 |
Phf12 |
PHD finger protein 12 |
100 |
0.95 |
chr7_28742166_28742510 | 12.33 |
Sars2 |
seryl-aminoacyl-tRNA synthetase 2 |
330 |
0.57 |
chr3_54735027_54735198 | 12.32 |
Exosc8 |
exosome component 8 |
66 |
0.85 |
chr11_69632367_69632996 | 12.32 |
Fxr2 |
fragile X mental retardation, autosomal homolog 2 |
309 |
0.58 |
chr1_136346085_136346293 | 12.22 |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
85 |
0.97 |
chr18_46526029_46526396 | 12.19 |
Fem1c |
fem 1 homolog c |
241 |
0.9 |
chr4_141538661_141539273 | 12.14 |
Spen |
spen family transcription repressor |
370 |
0.81 |
chr12_78861950_78862376 | 12.05 |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
33 |
0.9 |
chr5_137786077_137787112 | 11.97 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr17_56584724_56585052 | 11.91 |
Safb |
scaffold attachment factor B |
63 |
0.78 |
chr10_86021762_86021984 | 11.88 |
Fbxo7 |
F-box protein 7 |
99 |
0.83 |
chr14_61648694_61649063 | 11.88 |
Dleu2 |
deleted in lymphocytic leukemia, 2 |
56 |
0.5 |
chr15_88751323_88752215 | 11.87 |
Zbed4 |
zinc finger, BED type containing 4 |
9 |
0.98 |
chr18_10182030_10182284 | 11.78 |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
112 |
0.95 |
chr15_102470670_102471447 | 11.64 |
Pcbp2 |
poly(rC) binding protein 2 |
10 |
0.95 |
chr7_126649513_126649711 | 11.61 |
2510046G10Rik |
RIKEN cDNA 2510046G10 gene |
18 |
0.71 |
chr14_69732478_69732890 | 11.60 |
Chmp7 |
charged multivesicular body protein 7 |
143 |
0.94 |
chr7_4658910_4659251 | 11.57 |
Ppp6r1 |
protein phosphatase 6, regulatory subunit 1 |
61 |
0.83 |
chr19_45783453_45784021 | 11.41 |
Oga |
O-GlcNAcase |
39 |
0.97 |
chr4_135353109_135353806 | 11.41 |
Srrm1 |
serine/arginine repetitive matrix 1 |
136 |
0.93 |
chr19_32239325_32239637 | 11.37 |
Sgms1 |
sphingomyelin synthase 1 |
655 |
0.76 |
chr2_173736867_173737587 | 11.28 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
284 |
0.88 |
chr19_24477429_24477614 | 11.27 |
Fam122a |
family with sequence similarity 122, member A |
165 |
0.96 |
chr5_33018563_33018867 | 11.14 |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
101 |
0.96 |
chr5_115631746_115632284 | 11.12 |
Rab35 |
RAB35, member RAS oncogene family |
107 |
0.62 |
chr2_125672649_125673141 | 11.08 |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
200 |
0.82 |
chr11_59449917_59450126 | 11.01 |
Snap47 |
synaptosomal-associated protein, 47 |
14 |
0.49 |
chr6_126939455_126939771 | 10.96 |
Rad51ap1 |
RAD51 associated protein 1 |
26 |
0.83 |
chr6_38924531_38924702 | 10.94 |
Tbxas1 |
thromboxane A synthase 1, platelet |
5592 |
0.22 |
chr7_17074444_17074622 | 10.93 |
Psg16 |
pregnancy specific glycoprotein 16 |
415 |
0.73 |
chr11_107012597_107012919 | 10.91 |
Gm11708 |
predicted gene 11708 |
8018 |
0.13 |
chr15_80087655_80087812 | 10.85 |
Gm24204 |
predicted gene, 24204 |
820 |
0.4 |
chr9_70503708_70503969 | 10.81 |
Rnf111 |
ring finger 111 |
113 |
0.95 |
chr9_110656642_110656914 | 10.80 |
Ccdc12 |
coiled-coil domain containing 12 |
166 |
0.87 |
chr16_37653614_37654984 | 10.75 |
Ndufb4 |
NADH:ubiquinone oxidoreductase subunit B4 |
67 |
0.97 |
chr19_4397000_4397495 | 10.67 |
Kdm2a |
lysine (K)-specific demethylase 2A |
152 |
0.93 |
chr11_22971835_22972705 | 10.58 |
Zrsr1 |
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 1 |
265 |
0.72 |
chr10_95564038_95564403 | 10.56 |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
74 |
0.96 |
chr12_110696238_110696730 | 10.54 |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
89 |
0.95 |
chr10_81997201_81997571 | 10.54 |
Gm8158 |
predicted gene 8158 |
10984 |
0.09 |
chr18_36454374_36454723 | 10.54 |
Pfdn1 |
prefoldin 1 |
24 |
0.98 |
chr4_135494313_135495270 | 10.53 |
Stpg1 |
sperm tail PG rich repeat containing 1 |
1 |
0.68 |
chr14_64440050_64440758 | 10.49 |
Msra |
methionine sulfoxide reductase A |
513 |
0.85 |
chr6_13069699_13069921 | 10.46 |
Tmem106b |
transmembrane protein 106B |
6 |
0.98 |
chr19_8819727_8820229 | 10.45 |
Hnrnpul2 |
heterogeneous nuclear ribonucleoprotein U-like 2 |
32 |
0.86 |
chr8_94172343_94172819 | 10.43 |
Mt2 |
metallothionein 2 |
83 |
0.91 |
chr3_108444711_108445345 | 10.41 |
Sars |
seryl-aminoacyl-tRNA synthetase |
115 |
0.92 |
chr16_49855438_49855806 | 10.35 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
11 |
0.99 |
chr10_81266558_81266830 | 10.32 |
Mrpl54 |
mitochondrial ribosomal protein L54 |
230 |
0.48 |
chr19_41911497_41912107 | 10.25 |
Pgam1 |
phosphoglycerate mutase 1 |
121 |
0.93 |
chr5_77310377_77310565 | 10.20 |
Polr2b |
polymerase (RNA) II (DNA directed) polypeptide B |
20 |
0.86 |
chr11_69921274_69921508 | 10.19 |
Eif5a |
eukaryotic translation initiation factor 5A |
5 |
0.92 |
chr1_185203642_185204638 | 10.16 |
Rab3gap2 |
RAB3 GTPase activating protein subunit 2 |
23 |
0.97 |
chr12_84996056_84996434 | 10.09 |
Ylpm1 |
YLP motif containing 1 |
76 |
0.96 |
chr19_7482545_7483560 | 10.06 |
Rtn3 |
reticulon 3 |
150 |
0.94 |
chr5_93206745_93206954 | 10.06 |
2010109A12Rik |
RIKEN cDNA 2010109A12 gene |
316 |
0.5 |
chr17_69382802_69383119 | 10.05 |
Zbtb14 |
zinc finger and BTB domain containing 14 |
90 |
0.94 |
chr7_143822737_143823137 | 10.01 |
Nadsyn1 |
NAD synthetase 1 |
88 |
0.66 |
chr7_127017249_127017562 | 10.00 |
Pagr1a |
PAXIP1 associated glutamate rich protein 1A |
53 |
0.47 |
chr14_60264990_60265776 | 10.00 |
Mtmr6 |
myotubularin related protein 6 |
45 |
0.97 |
chr13_69534641_69534812 | 9.94 |
Tent4a |
terminal nucleotidyltransferase 4A |
109 |
0.92 |
chrX_48513407_48513768 | 9.92 |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
24 |
0.97 |
chr16_90727245_90727548 | 9.91 |
Mis18a |
MIS18 kinetochore protein A |
8 |
0.97 |
chr1_37865182_37865405 | 9.89 |
Gm26805 |
predicted gene, 26805 |
6 |
0.73 |
chr16_96145178_96145377 | 9.88 |
Get1 |
guided entry of tail-anchored proteins factor 1 |
130 |
0.93 |
chr19_24513856_24514007 | 9.81 |
Fam122a |
family with sequence similarity 122, member A |
36575 |
0.14 |
chr14_55106214_55106427 | 9.80 |
Ap1g2 |
adaptor protein complex AP-1, gamma 2 subunit |
53 |
0.94 |
chr6_146577102_146577646 | 9.78 |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
171 |
0.75 |
chr6_118562212_118562425 | 9.77 |
Ankrd26 |
ankyrin repeat domain 26 |
92 |
0.97 |
chr15_31224173_31224992 | 9.73 |
Dap |
death-associated protein |
22 |
0.98 |
chr3_35932298_35933364 | 9.72 |
Dcun1d1 |
DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) |
5 |
0.73 |
chr16_32332026_32332290 | 9.72 |
Ubxn7 |
UBX domain protein 7 |
99 |
0.95 |
chr14_75178641_75178799 | 9.67 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2512 |
0.23 |
chr9_101034875_101035077 | 9.63 |
Pccb |
propionyl Coenzyme A carboxylase, beta polypeptide |
78 |
0.96 |
chr12_85824837_85825296 | 9.61 |
Ttll5 |
tubulin tyrosine ligase-like family, member 5 |
9 |
0.91 |
chr4_129742217_129742454 | 9.59 |
Khdrbs1 |
KH domain containing, RNA binding, signal transduction associated 1 |
32 |
0.96 |
chr8_9975933_9976588 | 9.59 |
Lig4 |
ligase IV, DNA, ATP-dependent |
39 |
0.96 |
chr7_4658481_4658864 | 9.58 |
Gm44878 |
predicted gene 44878 |
12 |
0.8 |
chr4_83525216_83526037 | 9.57 |
Ccdc171 |
coiled-coil domain containing 171 |
12 |
0.96 |
chr17_35135082_35135254 | 9.52 |
Bag6 |
BCL2-associated athanogene 6 |
10 |
0.89 |
chr5_30960153_30960693 | 9.48 |
Preb |
prolactin regulatory element binding |
62 |
0.94 |
chr16_20547980_20548703 | 9.46 |
Gm15760 |
predicted gene 15760 |
115 |
0.64 |
chr18_70530231_70530511 | 9.45 |
Poli |
polymerase (DNA directed), iota |
63 |
0.97 |
chr1_34849865_34850510 | 9.44 |
Plekhb2 |
pleckstrin homology domain containing, family B (evectins) member 2 |
195 |
0.92 |
chr14_103346799_103347211 | 9.44 |
Mycbp2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
191 |
0.95 |
chr13_107022283_107023054 | 9.37 |
3830408C21Rik |
RIKEN cDNA 3830408C21 gene |
98 |
0.87 |
chr10_75212252_75212438 | 9.36 |
Specc1l |
sperm antigen with calponin homology and coiled-coil domains 1-like |
45 |
0.98 |
chr7_28981963_28982879 | 9.32 |
Map4k1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
371 |
0.56 |
chr10_59322828_59323498 | 9.29 |
P4ha1 |
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide |
133 |
0.97 |
chr18_74267773_74268322 | 9.28 |
Mbd1 |
methyl-CpG binding domain protein 1 |
128 |
0.95 |
chrX_8175855_8176063 | 9.27 |
Tbc1d25 |
TBC1 domain family, member 25 |
1 |
0.95 |
chr2_156991546_156992589 | 9.26 |
Ndrg3 |
N-myc downstream regulated gene 3 |
11 |
0.96 |
chr12_110737482_110738077 | 9.23 |
Wdr20 |
WD repeat domain 20 |
165 |
0.94 |
chr8_123065306_123065596 | 9.21 |
Spg7 |
SPG7, paraplegin matrix AAA peptidase subunit |
25 |
0.95 |
chr11_69758107_69758388 | 9.20 |
Polr2a |
polymerase (RNA) II (DNA directed) polypeptide A |
24 |
0.92 |
chr5_74535200_74535558 | 9.19 |
Fip1l1 |
FIP1 like 1 (S. cerevisiae) |
70 |
0.97 |
chr2_119896787_119897358 | 9.16 |
Mga |
MAX gene associated |
156 |
0.95 |
chr1_176813990_176814449 | 9.15 |
Cep170 |
centrosomal protein 170 |
152 |
0.78 |
chr6_88627327_88627771 | 9.14 |
Kbtbd12 |
kelch repeat and BTB (POZ) domain containing 12 |
101 |
0.97 |
chr4_21848391_21848567 | 9.12 |
Pnisr |
PNN interacting serine/arginine-rich |
398 |
0.86 |
chr13_24831097_24832309 | 9.11 |
Tdp2 |
tyrosyl-DNA phosphodiesterase 2 |
7 |
0.67 |
chr15_85811549_85811881 | 9.10 |
Cdpf1 |
cysteine rich, DPF motif domain containing 1 |
18 |
0.97 |
chr15_102670570_102671462 | 9.10 |
Atp5g2 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9) |
111 |
0.9 |
chr11_101119709_101120144 | 9.08 |
Tubg1 |
tubulin, gamma 1 |
12 |
0.5 |
chr10_71344528_71345300 | 9.06 |
Cisd1 |
CDGSH iron sulfur domain 1 |
40 |
0.96 |
chr19_7240431_7241403 | 9.04 |
Naa40 |
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
117 |
0.93 |
chr1_92180769_92180995 | 8.81 |
Hdac4 |
histone deacetylase 4 |
541 |
0.84 |
chr6_71543761_71544010 | 8.80 |
Chmp3 |
charged multivesicular body protein 3 |
7 |
0.74 |
chr10_62332364_62332898 | 8.80 |
Hk1 |
hexokinase 1 |
4864 |
0.18 |
chr4_135433425_135434105 | 8.78 |
Rcan3 |
regulator of calcineurin 3 |
58 |
0.94 |
chr15_83594680_83595390 | 8.77 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
122 |
0.95 |
chr1_135941196_135941555 | 8.75 |
Igfn1 |
immunoglobulin-like and fibronectin type III domain containing 1 |
21765 |
0.12 |
chr11_3289074_3290615 | 8.73 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr7_28811273_28811637 | 8.67 |
Hnrnpl |
heterogeneous nuclear ribonucleoprotein L |
515 |
0.5 |
chr3_31094782_31094964 | 8.63 |
Skil |
SKI-like |
185 |
0.95 |
chr4_140701770_140702866 | 8.61 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr12_111966896_111967219 | 8.60 |
Atp5mpl |
ATP synthase membrane subunit 6.8PL |
80 |
0.95 |
chr1_121430948_121431416 | 8.59 |
Ccdc93 |
coiled-coil domain containing 93 |
72 |
0.97 |
chr7_28961583_28962604 | 8.58 |
Actn4 |
actinin alpha 4 |
130 |
0.93 |
chr8_14888678_14889479 | 8.57 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
74 |
0.97 |
chr3_113629607_113629974 | 8.55 |
Rnpc3 |
RNA-binding region (RNP1, RRM) containing 3 |
110 |
0.96 |
chr9_110304985_110305255 | 8.54 |
Elp6 |
elongator acetyltransferase complex subunit 6 |
53 |
0.95 |
chr11_54955757_54955988 | 8.50 |
Tnip1 |
TNFAIP3 interacting protein 1 |
175 |
0.94 |
chr10_82128201_82128572 | 8.49 |
AU041133 |
expressed sequence AU041133 |
373 |
0.8 |
chr9_66511382_66512321 | 8.40 |
Fbxl22 |
F-box and leucine-rich repeat protein 22 |
2758 |
0.23 |
chr13_73466889_73467305 | 8.38 |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
100 |
0.97 |
chr10_62237323_62237501 | 8.37 |
Tspan15 |
tetraspanin 15 |
6161 |
0.17 |
chr9_122351224_122352269 | 8.37 |
Abhd5 |
abhydrolase domain containing 5 |
1 |
0.97 |
chr17_24724325_24724525 | 8.28 |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
5 |
0.91 |
chr13_58520193_58520350 | 8.28 |
Gm3131 |
predicted gene 3131 |
25757 |
0.15 |
chr11_115186835_115187966 | 8.28 |
Nat9 |
N-acetyltransferase 9 (GCN5-related, putative) |
10 |
0.56 |
chr10_128231921_128232461 | 8.27 |
Timeless |
timeless circadian clock 1 |
57 |
0.93 |
chr15_68363006_68363408 | 8.22 |
Gm20732 |
predicted gene 20732 |
31 |
0.97 |
chr11_103953918_103954240 | 8.20 |
Nsf |
N-ethylmaleimide sensitive fusion protein |
23 |
0.98 |
chr10_84622505_84622710 | 8.20 |
Gm17249 |
predicted gene, 17249 |
29 |
0.82 |
chr4_155563699_155564268 | 8.20 |
Nadk |
NAD kinase |
75 |
0.95 |
chr7_101310656_101311052 | 8.19 |
Stard10 |
START domain containing 10 |
6232 |
0.11 |
chr12_98747147_98747334 | 8.16 |
Zc3h14 |
zinc finger CCCH type containing 14 |
233 |
0.88 |
chr14_63122602_63122983 | 8.14 |
Ctsb |
cathepsin B |
278 |
0.87 |
chr19_60790623_60790812 | 8.14 |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
59 |
0.95 |
chr11_95414546_95415043 | 8.14 |
Spop |
speckle-type BTB/POZ protein |
551 |
0.69 |
chr14_31336088_31336786 | 8.13 |
Capn7 |
calpain 7 |
201 |
0.9 |
chr6_128424454_128424771 | 8.11 |
Itfg2 |
integrin alpha FG-GAP repeat containing 2 |
257 |
0.8 |
chr5_106964155_106965054 | 8.10 |
Cdc7 |
cell division cycle 7 (S. cerevisiae) |
43 |
0.98 |
chr10_80622517_80622780 | 8.10 |
Csnk1g2 |
casein kinase 1, gamma 2 |
190 |
0.85 |
chr11_22972777_22973003 | 8.08 |
Commd1 |
COMM domain containing 1 |
31 |
0.82 |
chr6_116193449_116194016 | 8.07 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
246 |
0.86 |
chr1_86487302_86488257 | 8.06 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
14120 |
0.13 |
chr3_19628040_19628404 | 8.03 |
1700064H15Rik |
RIKEN cDNA 1700064H15 gene |
455 |
0.79 |
chr3_58576457_58576809 | 8.02 |
Selenot |
selenoprotein T |
3 |
0.97 |
chr10_80039686_80039982 | 8.02 |
Polr2e |
polymerase (RNA) II (DNA directed) polypeptide E |
39 |
0.94 |
chr9_53536593_53537662 | 8.02 |
Npat |
nuclear protein in the AT region |
80 |
0.83 |
chr8_107425009_107425206 | 8.01 |
Nob1 |
NIN1/RPN12 binding protein 1 homolog |
56 |
0.96 |
chr17_74338356_74338962 | 8.00 |
Spast |
spastin |
328 |
0.81 |
chr2_154892731_154893320 | 7.99 |
Eif2s2 |
eukaryotic translation initiation factor 2, subunit 2 (beta) |
90 |
0.97 |
chr8_70234072_70234262 | 7.96 |
Armc6 |
armadillo repeat containing 6 |
41 |
0.51 |
chr5_145083646_145083957 | 7.94 |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
29 |
0.73 |
chr17_24351717_24352660 | 7.87 |
Abca3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
86 |
0.92 |
chr16_14317014_14317200 | 7.87 |
Fopnl |
Fgfr1op N-terminal like |
225 |
0.91 |
chr8_70138821_70139424 | 7.84 |
Rfxank |
regulatory factor X-associated ankyrin-containing protein |
26 |
0.79 |
chr1_60098158_60098338 | 7.84 |
Carf |
calcium response factor |
1 |
0.59 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 17.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
5.0 | 15.1 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
4.9 | 14.8 | GO:0021553 | olfactory nerve development(GO:0021553) |
4.9 | 24.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
4.8 | 19.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
4.8 | 14.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
4.8 | 14.4 | GO:0040031 | snRNA modification(GO:0040031) |
4.7 | 14.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
4.3 | 13.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
4.2 | 17.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
3.9 | 15.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.8 | 7.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
3.7 | 3.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
3.7 | 11.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
3.7 | 11.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.6 | 10.9 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
3.6 | 10.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
3.5 | 10.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
3.5 | 10.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
3.5 | 10.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.4 | 13.5 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
3.3 | 20.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
3.3 | 10.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
3.3 | 10.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
3.3 | 13.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
3.3 | 3.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
3.2 | 9.7 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
3.2 | 12.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
3.2 | 15.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
3.1 | 9.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.1 | 12.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
3.1 | 15.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
3.1 | 6.2 | GO:0045472 | response to ether(GO:0045472) |
3.1 | 3.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
3.1 | 9.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
3.0 | 5.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
3.0 | 5.9 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
3.0 | 8.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.9 | 11.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
2.9 | 8.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
2.9 | 8.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
2.9 | 23.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.9 | 8.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.8 | 14.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
2.8 | 8.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.7 | 8.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.7 | 10.9 | GO:0034214 | protein hexamerization(GO:0034214) |
2.7 | 16.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
2.6 | 15.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.6 | 13.2 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.6 | 7.9 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
2.6 | 10.4 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
2.6 | 7.8 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
2.6 | 7.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
2.6 | 20.7 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
2.6 | 7.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
2.6 | 15.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
2.6 | 23.0 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
2.6 | 10.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
2.5 | 7.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.5 | 12.5 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
2.4 | 7.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.4 | 12.2 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
2.4 | 9.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.4 | 7.3 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
2.4 | 7.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.4 | 4.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.4 | 2.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.4 | 7.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.4 | 7.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
2.3 | 7.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
2.3 | 7.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.3 | 13.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
2.3 | 9.3 | GO:0008228 | opsonization(GO:0008228) |
2.3 | 7.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
2.3 | 11.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.3 | 7.0 | GO:0009249 | protein lipoylation(GO:0009249) |
2.3 | 11.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
2.2 | 9.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
2.2 | 6.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
2.2 | 8.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
2.2 | 2.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
2.2 | 13.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
2.2 | 8.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
2.2 | 6.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
2.2 | 12.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
2.1 | 4.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
2.1 | 4.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.1 | 10.6 | GO:0080009 | mRNA methylation(GO:0080009) |
2.1 | 8.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
2.1 | 14.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
2.1 | 6.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.1 | 10.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
2.1 | 6.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.1 | 6.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
2.1 | 2.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.1 | 14.6 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
2.1 | 6.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
2.1 | 4.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
2.0 | 10.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
2.0 | 10.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
2.0 | 10.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
2.0 | 12.2 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
2.0 | 8.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.0 | 16.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
2.0 | 4.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
2.0 | 8.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.0 | 14.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
2.0 | 2.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
2.0 | 6.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.0 | 7.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
2.0 | 7.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.0 | 11.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
2.0 | 9.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
2.0 | 9.8 | GO:0006983 | ER overload response(GO:0006983) |
1.9 | 7.8 | GO:0030091 | protein repair(GO:0030091) |
1.9 | 9.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.9 | 3.8 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
1.9 | 5.7 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.9 | 3.8 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
1.9 | 5.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.9 | 29.9 | GO:0016180 | snRNA processing(GO:0016180) |
1.9 | 5.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.9 | 14.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.9 | 3.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.9 | 7.4 | GO:0019230 | proprioception(GO:0019230) |
1.8 | 5.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.8 | 7.4 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.8 | 9.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.8 | 9.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
1.8 | 5.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.8 | 7.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.8 | 5.5 | GO:0015744 | succinate transport(GO:0015744) |
1.8 | 18.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.8 | 1.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.8 | 19.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.8 | 10.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.8 | 9.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.8 | 26.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.8 | 5.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.8 | 5.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.8 | 1.8 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.7 | 12.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
1.7 | 8.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.7 | 8.6 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
1.7 | 10.3 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
1.7 | 10.2 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
1.7 | 8.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.7 | 6.8 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.7 | 8.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 5.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.7 | 5.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.7 | 3.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.7 | 11.6 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
1.6 | 11.5 | GO:1901660 | calcium ion export(GO:1901660) |
1.6 | 8.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
1.6 | 21.2 | GO:0045116 | protein neddylation(GO:0045116) |
1.6 | 11.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.6 | 3.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.6 | 9.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
1.6 | 9.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.6 | 11.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.6 | 8.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.6 | 4.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.6 | 4.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.6 | 4.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.6 | 23.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.6 | 4.8 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.6 | 19.0 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
1.6 | 6.3 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.6 | 25.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.6 | 9.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.6 | 6.3 | GO:0043144 | snoRNA processing(GO:0043144) |
1.6 | 4.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.6 | 3.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.6 | 6.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.5 | 27.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.5 | 10.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.5 | 6.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.5 | 10.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.5 | 3.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.5 | 3.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
1.5 | 15.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.5 | 3.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.5 | 13.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
1.5 | 4.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.5 | 4.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.5 | 4.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.5 | 2.9 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.5 | 7.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.5 | 8.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.5 | 4.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.5 | 8.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.5 | 7.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
1.5 | 13.1 | GO:0009650 | UV protection(GO:0009650) |
1.5 | 5.8 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
1.5 | 5.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.5 | 7.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
1.5 | 2.9 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
1.5 | 4.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.4 | 5.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.4 | 5.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.4 | 5.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.4 | 5.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.4 | 7.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.4 | 12.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.4 | 5.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.4 | 21.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.4 | 5.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.4 | 8.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.4 | 8.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.4 | 5.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.4 | 4.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.4 | 4.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.4 | 2.7 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
1.4 | 20.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.4 | 4.1 | GO:0097503 | sialylation(GO:0097503) |
1.4 | 5.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.4 | 4.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.4 | 2.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.3 | 9.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.3 | 10.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.3 | 2.7 | GO:0001302 | replicative cell aging(GO:0001302) |
1.3 | 4.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.3 | 2.6 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
1.3 | 4.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.3 | 4.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.3 | 2.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.3 | 15.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.3 | 3.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
1.3 | 3.9 | GO:0019086 | late viral transcription(GO:0019086) |
1.3 | 6.5 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
1.3 | 2.6 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
1.3 | 3.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.3 | 3.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.3 | 1.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.3 | 46.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
1.3 | 6.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.3 | 6.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
1.3 | 3.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.3 | 2.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.3 | 7.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.3 | 7.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.3 | 5.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.3 | 6.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.3 | 8.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.2 | 3.7 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.2 | 10.0 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.2 | 9.9 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
1.2 | 3.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.2 | 9.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.2 | 7.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.2 | 3.7 | GO:0008050 | female courtship behavior(GO:0008050) |
1.2 | 6.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.2 | 2.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.2 | 3.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.2 | 3.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.2 | 6.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.2 | 4.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.2 | 4.8 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
1.2 | 8.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.2 | 3.6 | GO:1904429 | regulation of t-circle formation(GO:1904429) negative regulation of t-circle formation(GO:1904430) |
1.2 | 3.6 | GO:0000012 | single strand break repair(GO:0000012) |
1.2 | 2.4 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
1.2 | 4.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.2 | 6.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.2 | 8.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.2 | 2.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.2 | 9.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.2 | 2.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.2 | 2.4 | GO:1903416 | response to glycoside(GO:1903416) |
1.2 | 7.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.2 | 4.8 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.2 | 2.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.2 | 15.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.2 | 5.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.2 | 3.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.2 | 3.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.2 | 1.2 | GO:0009301 | snRNA transcription(GO:0009301) |
1.2 | 3.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
1.2 | 4.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.2 | 1.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.2 | 3.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.2 | 15.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.2 | 1.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
1.2 | 5.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.2 | 3.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.2 | 2.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.2 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.2 | 12.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
1.2 | 9.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
1.2 | 38.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.2 | 6.9 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
1.2 | 13.8 | GO:0046697 | decidualization(GO:0046697) |
1.1 | 11.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.1 | 3.4 | GO:0002432 | granuloma formation(GO:0002432) |
1.1 | 12.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
1.1 | 9.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.1 | 15.7 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
1.1 | 3.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
1.1 | 17.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.1 | 5.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.1 | 3.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.1 | 3.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.1 | 3.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.1 | 4.4 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.1 | 12.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.1 | 10.9 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.1 | 4.4 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
1.1 | 4.3 | GO:0070076 | histone lysine demethylation(GO:0070076) |
1.1 | 10.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.1 | 1.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.1 | 3.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.1 | 5.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.1 | 7.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.1 | 3.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.1 | 2.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.1 | 19.2 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
1.1 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
1.1 | 1.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
1.1 | 3.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.1 | 3.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.1 | 7.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.1 | 8.4 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
1.1 | 4.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.0 | 24.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.0 | 3.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.0 | 3.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
1.0 | 20.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.0 | 3.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.0 | 4.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.0 | 3.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.0 | 2.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.0 | 7.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.0 | 1.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.0 | 1.0 | GO:0043622 | cortical microtubule organization(GO:0043622) |
1.0 | 11.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.0 | 15.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
1.0 | 5.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.0 | 4.0 | GO:0006415 | translational termination(GO:0006415) |
1.0 | 6.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 3.0 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.0 | 4.0 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
1.0 | 2.0 | GO:0030576 | Cajal body organization(GO:0030576) |
1.0 | 32.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.0 | 4.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.0 | 4.0 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
1.0 | 2.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.0 | 7.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.0 | 15.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
1.0 | 1.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.0 | 8.6 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.0 | 6.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.9 | 17.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.9 | 0.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.9 | 4.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.9 | 1.9 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.9 | 11.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.9 | 10.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.9 | 6.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.9 | 8.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.9 | 8.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.9 | 2.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.9 | 2.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.9 | 7.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.9 | 1.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.9 | 1.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.9 | 9.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.9 | 9.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.9 | 1.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.9 | 2.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 7.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 15.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.9 | 2.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.9 | 6.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.9 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.9 | 2.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.9 | 2.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.9 | 5.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.9 | 7.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.9 | 1.7 | GO:0000087 | mitotic M phase(GO:0000087) |
0.9 | 14.0 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.9 | 4.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.9 | 7.0 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.9 | 2.6 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.9 | 5.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 5.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.9 | 13.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.9 | 3.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.9 | 3.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.9 | 4.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 6.9 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.9 | 1.7 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.9 | 7.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.9 | 1.7 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.8 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.8 | 2.5 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.8 | 3.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.8 | 7.6 | GO:0019359 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.8 | 13.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.8 | 4.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.8 | 10.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.8 | 5.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.8 | 2.5 | GO:1900126 | regulation of hyaluronan biosynthetic process(GO:1900125) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 3.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.8 | 6.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.8 | 0.8 | GO:1901563 | response to camptothecin(GO:1901563) |
0.8 | 4.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 23.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.8 | 2.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.8 | 2.5 | GO:0009838 | abscission(GO:0009838) |
0.8 | 2.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.8 | 5.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 1.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 2.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.8 | 2.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.8 | 1.6 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.8 | 3.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.8 | 2.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 2.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.8 | 0.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 1.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.8 | 2.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.8 | 12.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.8 | 3.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.8 | 1.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.8 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 17.3 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.8 | 8.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.8 | 100.3 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.8 | 2.3 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.8 | 12.5 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.8 | 7.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.8 | 1.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.8 | 0.8 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.8 | 4.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.8 | 12.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.8 | 2.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 1.5 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.8 | 3.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.8 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.8 | 1.5 | GO:0050904 | diapedesis(GO:0050904) |
0.7 | 7.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.7 | 13.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.7 | 5.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.7 | 3.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.7 | 1.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.7 | 8.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 1.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.7 | 2.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.7 | 3.6 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.7 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 2.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.7 | 34.4 | GO:0006413 | translational initiation(GO:0006413) |
0.7 | 5.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.7 | 2.9 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.7 | 4.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.7 | 10.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.7 | 5.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 2.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.7 | 4.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.7 | 2.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.7 | 2.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.7 | 1.4 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.7 | 2.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.7 | 1.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.7 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 2.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.7 | 4.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.7 | 2.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.7 | 3.5 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.7 | 2.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.7 | 2.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 8.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.7 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 3.5 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.7 | 4.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 2.8 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.7 | 2.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.7 | 2.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 2.7 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.7 | 4.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.7 | 1.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.7 | 12.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.7 | 5.4 | GO:0042026 | protein refolding(GO:0042026) |
0.7 | 5.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.7 | 2.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.7 | 3.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.7 | 3.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.7 | 15.5 | GO:0006414 | translational elongation(GO:0006414) |
0.7 | 6.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.7 | 8.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.7 | 1.3 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.7 | 4.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.7 | 1.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.7 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 2.0 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.7 | 10.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.7 | 31.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.7 | 0.7 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.7 | 4.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.7 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.7 | 2.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 3.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.7 | 2.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.7 | 3.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 5.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 9.7 | GO:0016573 | histone acetylation(GO:0016573) |
0.6 | 2.6 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.6 | 15.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.6 | 3.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 3.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.6 | 16.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.6 | 2.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.6 | 12.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.6 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 0.6 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.6 | 1.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 | 1.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.6 | 11.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.6 | 1.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.6 | 8.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.6 | 1.9 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.6 | 1.9 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.6 | 3.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 23.0 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.6 | 1.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.6 | 1.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 25.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.6 | 6.7 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.6 | 6.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.6 | 2.4 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.6 | 0.6 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.6 | 1.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 3.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.6 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 6.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 1.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.6 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.6 | 4.8 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.6 | 1.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.6 | 3.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 6.6 | GO:0051297 | centrosome organization(GO:0051297) |
0.6 | 11.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 1.2 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.6 | 1.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.6 | 1.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 1.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.6 | 5.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.6 | 5.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.6 | 1.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.6 | 0.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 1.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.6 | 2.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 1.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.6 | 6.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.6 | 3.5 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 2.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.6 | 1.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.6 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 2.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.6 | 2.8 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.6 | 0.6 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.6 | 49.8 | GO:0006457 | protein folding(GO:0006457) |
0.6 | 2.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 0.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.6 | 27.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 18.7 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.5 | 2.7 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 0.5 | GO:0043038 | amino acid activation(GO:0043038) |
0.5 | 2.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.5 | 4.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.5 | 2.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.5 | 17.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.5 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.5 | 1.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.5 | 2.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 1.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.5 | 1.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 8.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 7.4 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.5 | 7.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.5 | 2.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.5 | 1.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 3.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 0.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 3.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 7.8 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.5 | 2.1 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.5 | 10.3 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.5 | 3.1 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.5 | 1.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 3.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.5 | 1.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 5.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.5 | 1.5 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.5 | 8.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.5 | 2.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 4.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.5 | 1.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 6.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.5 | 8.1 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 0.5 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.5 | 1.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 1.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.5 | 1.0 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.5 | 1.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.5 | 4.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 7.5 | GO:0033273 | response to vitamin(GO:0033273) |
0.5 | 1.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 2.0 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.5 | 7.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.5 | 1.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 2.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.5 | 1.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.5 | 4.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 6.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 14.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.5 | 1.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.5 | 4.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.5 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.5 | 6.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.5 | 29.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.5 | 1.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 1.0 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.5 | 2.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.5 | 12.8 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.5 | 4.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.5 | 46.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.5 | 9.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.5 | 1.4 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.5 | 1.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 0.9 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.5 | 1.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.5 | 0.5 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.5 | 6.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.5 | 0.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.5 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.5 | 1.4 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.5 | 7.8 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.5 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.5 | 1.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 3.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.5 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 2.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 0.4 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.4 | 2.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 4.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 0.9 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 10.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 3.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 0.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 1.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.4 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.4 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 2.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 4.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 1.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.3 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.4 | 1.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 0.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 2.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.4 | 3.8 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 3.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.4 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.4 | 1.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 2.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.4 | 1.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 3.8 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.4 | 1.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 2.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.4 | 2.5 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.4 | 4.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 1.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 9.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.4 | 0.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 1.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 12.7 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 0.4 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.4 | 0.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 4.9 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.4 | 1.6 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.4 | 1.2 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.4 | 1.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.4 | 3.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.4 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 3.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.4 | 1.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.4 | 3.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.4 | 1.9 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.4 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.4 | 1.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.4 | 4.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.4 | 1.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.4 | 0.4 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 2.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 1.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.4 | 0.7 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.4 | 4.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 2.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 7.7 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.4 | 2.2 | GO:0036314 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.4 | 0.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 2.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.4 | 1.8 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 2.9 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 2.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 21.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.4 | 0.4 | GO:0071025 | RNA surveillance(GO:0071025) |
0.4 | 7.8 | GO:0042073 | intraciliary transport(GO:0042073) |
0.4 | 8.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 1.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 1.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 1.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 1.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 0.7 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 2.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.3 | 1.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.3 | 2.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 1.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 1.0 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.3 | 0.7 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.3 | 0.3 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 6.9 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.3 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 2.0 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 2.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 1.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 22.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.3 | 0.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 0.3 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.3 | 5.8 | GO:0048286 | lung alveolus development(GO:0048286) |
0.3 | 0.3 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 0.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 0.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 1.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 1.6 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.3 | 0.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 1.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 4.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 5.9 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 1.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.6 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.3 | 0.9 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.3 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 2.1 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 1.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 2.7 | GO:0043090 | amino acid import(GO:0043090) |
0.3 | 20.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.3 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 0.6 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 2.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 11.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 0.9 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 0.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 2.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 4.0 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) ribonucleotide catabolic process(GO:0009261) |
0.3 | 0.9 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.3 | 0.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.6 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.3 | 0.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 5.4 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.3 | 0.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.3 | 3.6 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.3 | 0.3 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.3 | 1.4 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 0.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 4.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.3 | 1.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 1.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.3 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 3.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.3 | 18.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 0.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 4.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 2.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 0.3 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 1.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 1.0 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.3 | 0.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 1.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 7.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.3 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.3 | 2.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.3 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 1.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 3.2 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.2 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 2.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 7.0 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 0.5 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 1.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 1.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.5 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.2 | 0.5 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 2.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 1.4 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 1.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 0.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 1.6 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.2 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 1.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 2.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 3.8 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 2.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.4 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.2 | 0.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 1.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 3.0 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.2 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 2.4 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.2 | 0.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 2.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 6.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.2 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 3.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 22.3 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.2 | 0.2 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.2 | 0.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 3.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 3.6 | GO:0010324 | membrane invagination(GO:0010324) |
0.2 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.6 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.2 | 0.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 2.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 12.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.6 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 0.2 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.6 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 2.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.4 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.2 | 0.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.7 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 0.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 1.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 2.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 1.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.2 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.2 | 1.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.7 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 4.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 1.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 2.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 2.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 1.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.2 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 0.2 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.3 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.2 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.8 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 2.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 1.2 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 4.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 1.4 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 1.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.7 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 1.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.1 | 1.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.3 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.1 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 1.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.1 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.1 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.4 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.1 | GO:0061317 | canonical Wnt signaling pathway involved in heart development(GO:0061316) canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:0006403 | RNA localization(GO:0006403) |
0.1 | 2.0 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 1.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 2.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 1.1 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.2 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.1 | 0.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 1.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.9 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.1 | 1.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.7 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 7.4 | GO:0042384 | cilium assembly(GO:0042384) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.1 | 0.4 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.1 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 0.2 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 1.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 1.7 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:0044065 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.1 | 1.4 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.4 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.1 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.1 | 0.2 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.8 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.1 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.1 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 1.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 1.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.4 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.1 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 1.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.5 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.8 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) platelet degranulation(GO:0002576) |
0.1 | 0.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.1 | 1.0 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.3 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.1 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.0 | 0.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.0 | GO:0009309 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.0 | 0.0 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.0 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.3 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.0 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.4 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.0 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.0 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.0 | 0.4 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.1 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
0.0 | 0.5 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.3 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.1 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.0 | GO:0042402 | cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.0 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.0 | 0.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.0 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.0 | 0.1 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.0 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.0 | 0.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.5 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.0 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 0.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0006473 | protein acetylation(GO:0006473) |
0.0 | 0.0 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.0 | 0.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.0 | 0.5 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
5.3 | 15.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
4.2 | 12.7 | GO:0005745 | m-AAA complex(GO:0005745) |
4.2 | 12.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
4.1 | 12.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
3.8 | 11.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
3.7 | 3.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
3.7 | 14.8 | GO:0005642 | annulate lamellae(GO:0005642) |
3.7 | 25.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
3.5 | 20.8 | GO:0031415 | NatA complex(GO:0031415) |
3.4 | 13.7 | GO:0035363 | histone locus body(GO:0035363) |
3.3 | 19.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
3.2 | 22.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
3.1 | 12.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
3.0 | 18.2 | GO:0005796 | Golgi lumen(GO:0005796) |
3.0 | 3.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
2.9 | 35.2 | GO:0016580 | Sin3 complex(GO:0016580) |
2.9 | 8.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.7 | 10.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.7 | 10.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.7 | 10.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.6 | 7.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
2.6 | 10.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
2.6 | 12.8 | GO:0000235 | astral microtubule(GO:0000235) |
2.5 | 41.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
2.4 | 34.2 | GO:0000974 | Prp19 complex(GO:0000974) |
2.4 | 9.7 | GO:0000322 | storage vacuole(GO:0000322) |
2.4 | 21.6 | GO:0005869 | dynactin complex(GO:0005869) |
2.4 | 7.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.4 | 9.4 | GO:1990130 | Iml1 complex(GO:1990130) |
2.3 | 7.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.3 | 21.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
2.3 | 25.1 | GO:0032039 | integrator complex(GO:0032039) |
2.2 | 6.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
2.2 | 6.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.2 | 8.7 | GO:0072487 | MSL complex(GO:0072487) |
2.2 | 10.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
2.2 | 10.8 | GO:0005638 | lamin filament(GO:0005638) |
2.2 | 19.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
2.2 | 6.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.2 | 28.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
2.1 | 25.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
2.1 | 6.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
2.1 | 6.3 | GO:0036396 | MIS complex(GO:0036396) |
2.1 | 14.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
2.1 | 14.5 | GO:0016272 | prefoldin complex(GO:0016272) |
2.0 | 4.1 | GO:0005688 | U6 snRNP(GO:0005688) |
2.0 | 30.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
2.0 | 4.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
2.0 | 22.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.0 | 6.0 | GO:0005712 | chiasma(GO:0005712) |
2.0 | 15.9 | GO:0001650 | fibrillar center(GO:0001650) |
1.9 | 13.3 | GO:0031931 | TORC1 complex(GO:0031931) |
1.9 | 7.6 | GO:0070545 | PeBoW complex(GO:0070545) |
1.9 | 7.5 | GO:0071797 | LUBAC complex(GO:0071797) |
1.9 | 13.1 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
1.9 | 5.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.9 | 27.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.9 | 5.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.8 | 5.5 | GO:0048179 | activin receptor complex(GO:0048179) |
1.8 | 5.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.8 | 5.5 | GO:0035838 | growing cell tip(GO:0035838) |
1.8 | 1.8 | GO:0031523 | Myb complex(GO:0031523) |
1.8 | 47.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.7 | 8.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.7 | 6.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.7 | 66.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.6 | 6.6 | GO:0032021 | NELF complex(GO:0032021) |
1.6 | 6.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.6 | 4.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.6 | 30.6 | GO:0045120 | pronucleus(GO:0045120) |
1.6 | 9.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
1.6 | 19.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.6 | 19.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.6 | 17.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.6 | 4.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.6 | 6.3 | GO:0000796 | condensin complex(GO:0000796) |
1.6 | 4.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.5 | 9.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.5 | 10.7 | GO:0005652 | nuclear lamina(GO:0005652) |
1.5 | 25.6 | GO:0097346 | INO80-type complex(GO:0097346) |
1.5 | 4.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.5 | 5.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.4 | 4.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.4 | 8.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.4 | 5.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.4 | 7.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.4 | 12.8 | GO:0000124 | SAGA complex(GO:0000124) |
1.4 | 16.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.4 | 4.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.4 | 36.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.4 | 13.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.4 | 8.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.4 | 26.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.4 | 4.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.4 | 6.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.4 | 4.1 | GO:0044393 | microspike(GO:0044393) |
1.4 | 5.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.3 | 18.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.3 | 2.7 | GO:0000125 | PCAF complex(GO:0000125) |
1.3 | 2.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.3 | 5.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.3 | 3.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.3 | 5.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.3 | 11.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.3 | 5.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.3 | 7.8 | GO:0038201 | TOR complex(GO:0038201) |
1.3 | 7.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.3 | 10.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.3 | 10.2 | GO:0031209 | SCAR complex(GO:0031209) |
1.3 | 12.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.3 | 15.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.3 | 6.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.3 | 12.6 | GO:0031143 | pseudopodium(GO:0031143) |
1.2 | 18.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.2 | 6.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.2 | 3.7 | GO:0071942 | XPC complex(GO:0071942) |
1.2 | 6.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.2 | 2.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.2 | 4.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.2 | 6.0 | GO:0005827 | polar microtubule(GO:0005827) |
1.2 | 8.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.2 | 16.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.2 | 4.7 | GO:0089701 | U2AF(GO:0089701) |
1.2 | 8.2 | GO:0030008 | TRAPP complex(GO:0030008) |
1.2 | 8.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.2 | 4.7 | GO:0098536 | deuterosome(GO:0098536) |
1.2 | 15.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.2 | 9.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.2 | 15.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.2 | 5.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
1.2 | 3.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.1 | 3.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.1 | 8.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.1 | 10.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.1 | 7.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.1 | 10.1 | GO:0014704 | intercalated disc(GO:0014704) |
1.1 | 52.2 | GO:0005643 | nuclear pore(GO:0005643) |
1.1 | 18.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.1 | 6.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.1 | 7.6 | GO:0042382 | paraspeckles(GO:0042382) |
1.0 | 9.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.0 | 5.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.0 | 6.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.0 | 5.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.0 | 5.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.0 | 6.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.0 | 20.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.0 | 2.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 2.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.0 | 4.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.9 | 3.8 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.9 | 2.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.9 | 9.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 2.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.9 | 15.7 | GO:0002102 | podosome(GO:0002102) |
0.9 | 7.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 7.3 | GO:0032797 | SMN complex(GO:0032797) |
0.9 | 7.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.9 | 2.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.9 | 2.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 3.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.9 | 2.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.9 | 1.8 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.9 | 18.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.9 | 2.7 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.9 | 8.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.9 | 0.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 10.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.9 | 6.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.9 | 28.9 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 5.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.8 | 4.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.8 | 10.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.8 | 11.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.8 | 8.2 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 3.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 3.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 28.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.8 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.8 | 2.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.8 | 4.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 2.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.8 | 5.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.8 | 54.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.8 | 7.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.8 | 3.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 3.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 2.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.8 | 9.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.8 | 7.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.7 | 3.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 10.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.7 | 10.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.7 | 19.8 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 5.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.7 | 2.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.7 | 2.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 73.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.7 | 5.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.7 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 20.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.7 | 50.5 | GO:0005814 | centriole(GO:0005814) |
0.7 | 2.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.7 | 9.1 | GO:0015030 | Cajal body(GO:0015030) |
0.7 | 5.6 | GO:0060091 | kinocilium(GO:0060091) |
0.7 | 6.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 3.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.7 | 3.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.7 | 18.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 6.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.7 | 36.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.7 | 6.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.7 | 4.1 | GO:0034464 | BBSome(GO:0034464) |
0.7 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 6.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.7 | 1.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.7 | 8.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 53.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.7 | 4.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.7 | 1.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.7 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 14.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.7 | 4.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 11.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.7 | 26.9 | GO:0016605 | PML body(GO:0016605) |
0.7 | 2.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.7 | 3.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 1.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.6 | 41.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 2.5 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 1.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 3.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 43.2 | GO:0030496 | midbody(GO:0030496) |
0.6 | 3.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 1.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 4.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
0.6 | 4.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.6 | 2.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 1.7 | GO:0097433 | dense body(GO:0097433) |
0.6 | 6.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.6 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 9.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.6 | 2.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.6 | 1.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.6 | 6.6 | GO:0030904 | retromer complex(GO:0030904) |
0.6 | 9.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.5 | 1.6 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 6.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.5 | 6.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.5 | 2.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.5 | 1.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.5 | 3.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 2.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.5 | 2.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 5.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 2.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 3.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.5 | 15.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 20.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 1.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 3.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.5 | 6.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 23.4 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 3.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 11.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 8.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 2.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 3.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.5 | 10.6 | GO:0031672 | A band(GO:0031672) |
0.5 | 19.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 20.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.5 | 11.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.5 | 7.5 | GO:0030684 | preribosome(GO:0030684) |
0.5 | 2.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 7.0 | GO:0000786 | nucleosome(GO:0000786) |
0.5 | 16.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.5 | 52.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.5 | 4.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 1.8 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 3.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 4.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 45.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.4 | 124.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.4 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 30.9 | GO:0005840 | ribosome(GO:0005840) |
0.4 | 1.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 1.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 420.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 170.2 | GO:0005730 | nucleolus(GO:0005730) |
0.4 | 16.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.4 | 1.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.4 | 1.2 | GO:0043601 | nuclear replisome(GO:0043601) |
0.4 | 4.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 11.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.4 | 1.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 1.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 2.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 6.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.4 | 1.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 363.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.4 | 1.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 1.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.4 | 0.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 3.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 0.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 3.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.3 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 1.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 1.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 5.5 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.3 | 3.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 1.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 1.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 1.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 6.2 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.3 | 3.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 3.1 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 170.7 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 1.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 26.5 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 1.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 13.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 4.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 14.9 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 3.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.2 | 2.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 17.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.0 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 3.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 77.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 4.7 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 1.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 2.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 113.1 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 1.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.8 | GO:1902494 | catalytic complex(GO:1902494) |
0.0 | 0.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 4.3 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0043205 | fibril(GO:0043205) |
0.0 | 15.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0032420 | stereocilium(GO:0032420) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 17.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
5.0 | 15.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
3.9 | 19.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
3.9 | 11.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
3.9 | 11.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
3.8 | 11.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
3.8 | 3.8 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
3.7 | 11.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.6 | 10.9 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
3.3 | 9.8 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
3.1 | 12.6 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
3.1 | 12.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
3.1 | 27.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.9 | 8.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
2.9 | 5.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
2.9 | 17.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
2.9 | 17.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.9 | 8.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.8 | 22.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
2.8 | 2.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.8 | 11.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.8 | 8.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.8 | 13.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.7 | 8.2 | GO:0004359 | glutaminase activity(GO:0004359) |
2.7 | 2.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
2.7 | 13.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.7 | 5.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
2.6 | 15.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.5 | 10.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
2.5 | 7.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
2.5 | 17.2 | GO:0030957 | Tat protein binding(GO:0030957) |
2.4 | 7.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
2.4 | 19.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
2.4 | 14.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
2.4 | 7.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.4 | 7.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.3 | 11.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.3 | 11.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
2.3 | 20.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
2.3 | 9.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.3 | 6.8 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
2.3 | 9.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.2 | 6.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.2 | 11.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.2 | 35.5 | GO:0008143 | poly(A) binding(GO:0008143) |
2.2 | 13.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
2.2 | 8.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.2 | 15.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
2.2 | 13.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
2.2 | 10.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
2.2 | 10.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.1 | 10.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.1 | 17.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.1 | 6.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
2.1 | 6.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.1 | 8.5 | GO:0009374 | biotin binding(GO:0009374) |
2.1 | 16.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.1 | 6.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
2.1 | 14.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.1 | 31.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
2.1 | 6.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
2.1 | 8.3 | GO:0030984 | kininogen binding(GO:0030984) |
2.1 | 10.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.1 | 12.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.0 | 24.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
2.0 | 18.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
2.0 | 6.1 | GO:0055100 | adiponectin binding(GO:0055100) |
2.0 | 8.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
2.0 | 19.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
2.0 | 2.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.0 | 4.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
2.0 | 17.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.0 | 5.9 | GO:0034786 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
2.0 | 5.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.9 | 5.8 | GO:0050693 | LBD domain binding(GO:0050693) |
1.9 | 5.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.9 | 5.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.9 | 15.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.9 | 7.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.8 | 7.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.8 | 5.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.8 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.8 | 7.3 | GO:0043515 | kinetochore binding(GO:0043515) |
1.8 | 5.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.8 | 3.5 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.7 | 22.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.7 | 8.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.7 | 17.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.7 | 5.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.7 | 6.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.7 | 21.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.7 | 5.0 | GO:0030519 | snoRNP binding(GO:0030519) |
1.6 | 3.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
1.6 | 4.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.6 | 8.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.6 | 1.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
1.6 | 6.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.6 | 4.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.6 | 7.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.6 | 12.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.6 | 6.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.5 | 4.6 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.5 | 4.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.5 | 1.5 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.5 | 6.1 | GO:0036033 | mediator complex binding(GO:0036033) |
1.5 | 6.0 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.5 | 4.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.4 | 4.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.4 | 4.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.4 | 7.1 | GO:0070728 | leucine binding(GO:0070728) |
1.4 | 64.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.4 | 7.0 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.4 | 7.0 | GO:0000339 | RNA cap binding(GO:0000339) |
1.4 | 2.7 | GO:1990188 | euchromatin binding(GO:1990188) |
1.4 | 4.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.3 | 4.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.3 | 1.3 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.3 | 4.0 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
1.3 | 49.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.3 | 10.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.3 | 5.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.3 | 5.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.3 | 14.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.3 | 3.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.3 | 23.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.3 | 1.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
1.3 | 5.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.3 | 7.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.3 | 3.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.3 | 6.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.3 | 3.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.3 | 53.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.3 | 18.9 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
1.3 | 17.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.3 | 3.8 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.3 | 8.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.3 | 3.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 31.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.2 | 3.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.2 | 3.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.2 | 22.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.2 | 3.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.2 | 4.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.2 | 13.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.2 | 9.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.2 | 8.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.2 | 25.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.2 | 10.8 | GO:0043022 | ribosome binding(GO:0043022) |
1.2 | 8.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.2 | 3.5 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.2 | 1.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.2 | 14.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.2 | 14.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.2 | 2.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
1.2 | 2.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.2 | 2.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.1 | 14.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.1 | 2.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.1 | 2.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
1.1 | 3.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.1 | 4.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 7.7 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.1 | 18.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.1 | 12.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.1 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.1 | 15.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.1 | 1.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
1.1 | 3.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.1 | 6.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.1 | 27.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.1 | 3.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.1 | 4.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.1 | 1.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.1 | 3.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.1 | 13.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.0 | 35.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.0 | 14.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.0 | 6.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.0 | 3.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.0 | 3.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.0 | 5.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.0 | 20.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.0 | 40.6 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
1.0 | 3.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.0 | 2.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.0 | 13.3 | GO:0018749 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
1.0 | 7.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
1.0 | 8.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 5.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.0 | 5.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.0 | 63.0 | GO:0008565 | protein transporter activity(GO:0008565) |
1.0 | 2.9 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
1.0 | 11.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.0 | 29.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.0 | 3.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.0 | 6.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.0 | 1.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.0 | 4.8 | GO:0048156 | tau protein binding(GO:0048156) |
1.0 | 2.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 0.9 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.9 | 14.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 6.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.9 | 36.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.9 | 5.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.9 | 12.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.9 | 28.7 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.9 | 4.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.9 | 1.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.9 | 2.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.9 | 3.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.9 | 15.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.9 | 3.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.9 | 2.7 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 8.1 | GO:0070513 | death domain binding(GO:0070513) |
0.9 | 3.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 0.9 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.9 | 2.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.9 | 15.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.9 | 2.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.9 | 17.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.9 | 3.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.9 | 0.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.9 | 9.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.9 | 16.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.9 | 6.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 46.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.8 | 6.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 5.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 1.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.8 | 2.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.8 | 2.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 19.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.8 | 6.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.8 | 7.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 4.2 | GO:0043820 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.8 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.8 | 2.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 3.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.8 | 23.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.8 | 3.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.8 | 6.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.8 | 15.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.8 | 8.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.8 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.8 | 3.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.8 | 1.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.8 | 3.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 4.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.8 | 2.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.8 | 13.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.8 | 6.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.8 | 3.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.8 | 4.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.8 | 4.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 28.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.8 | 8.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.8 | 1.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.8 | 5.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.8 | 3.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.8 | 2.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 2.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 4.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 17.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.7 | 11.9 | GO:0002039 | p53 binding(GO:0002039) |
0.7 | 0.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.7 | 18.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.7 | 4.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 4.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.7 | 28.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.7 | 5.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.7 | 16.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.7 | 2.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.7 | 14.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 5.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.7 | 2.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.7 | 3.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.7 | 102.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.7 | 8.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.7 | 9.2 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.7 | 6.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.7 | 2.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 4.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 2.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.7 | 7.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.7 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 2.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 5.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.7 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.7 | 2.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 2.0 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 19.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.7 | 10.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 15.0 | GO:0045502 | dynein binding(GO:0045502) |
0.7 | 2.0 | GO:0008443 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) |
0.7 | 3.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 1.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 13.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.6 | 5.2 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 3.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 5.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 40.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.6 | 2.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.6 | 5.7 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 8.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.6 | 30.1 | GO:0019003 | GDP binding(GO:0019003) |
0.6 | 1.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 2.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 2.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 12.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.6 | 5.5 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.6 | 0.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.6 | 4.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 6.5 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.6 | 40.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.6 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 7.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 1.8 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.6 | 2.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 2.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.6 | 4.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 58.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.6 | 6.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 447.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.6 | 6.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 9.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.6 | 4.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 29.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.6 | 0.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 9.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.6 | 48.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.6 | 2.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 5.0 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.6 | 4.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.6 | 28.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.6 | 2.2 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 1.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 9.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 2.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 1.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 3.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 3.1 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.5 | 1.6 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 3.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 2.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 1.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.5 | 0.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 1.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 4.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.5 | 5.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.5 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 1.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 3.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 1.4 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.5 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 5.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.5 | 28.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.5 | 1.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 1.4 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 2.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 2.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.5 | 9.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.5 | 1.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 1.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 1.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 1.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 6.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 1.4 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 0.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 9.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 0.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.8 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 7.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 3.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 2.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 2.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 5.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 8.0 | GO:0019239 | deaminase activity(GO:0019239) |
0.4 | 2.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 4.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 3.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 9.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.4 | 10.2 | GO:0030523 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.4 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 0.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 1.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 10.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 4.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.4 | 3.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 19.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.4 | 2.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 2.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.4 | 8.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 5.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.4 | 1.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.4 | 0.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 0.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.4 | 2.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 14.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 1.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 6.8 | GO:0005537 | mannose binding(GO:0005537) |
0.4 | 6.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 3.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 16.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 10.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 4.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 5.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.1 | GO:0038100 | nodal binding(GO:0038100) |
0.4 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.4 | 1.8 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 33.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.4 | 1.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 1.4 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.4 | 1.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 3.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 7.7 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 10.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 4.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 0.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 0.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 3.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 2.7 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.3 | 1.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 2.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 4.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.3 | 2.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.3 | 1.3 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.3 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 5.4 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 1.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 6.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 4.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 8.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 5.8 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.3 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 27.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 1.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 4.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 2.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 3.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 2.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.3 | 7.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 5.0 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 1.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 1.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.8 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 5.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 1.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 3.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 2.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.3 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 7.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 3.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 13.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 2.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 5.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 2.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 2.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 6.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 7.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 21.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 2.9 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 1.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 0.7 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 40.7 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 2.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 7.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 49.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 2.8 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 0.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 4.2 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.4 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 6.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 2.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 4.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 3.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 2.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 2.6 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.2 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 2.2 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 1.9 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 1.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 3.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 2.9 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 3.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 2.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 11.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 2.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.8 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 2.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 3.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 7.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.1 | 1.6 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 2.8 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 13.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 27.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.6 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 6.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 2.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.1 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0018650 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 1.6 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 8.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 0.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 2.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.0 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.6 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.7 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.4 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.0 | GO:0061733 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 2.5 | GO:0070011 | peptidase activity, acting on L-amino acid peptides(GO:0070011) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 3.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.0 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0030250 | cyclase regulator activity(GO:0010851) cyclase activator activity(GO:0010853) guanylate cyclase regulator activity(GO:0030249) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 23.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
2.0 | 67.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.8 | 3.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.7 | 3.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.7 | 20.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.6 | 24.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.6 | 9.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.5 | 21.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.4 | 38.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.3 | 32.3 | PID BARD1 PATHWAY | BARD1 signaling events |
1.3 | 18.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.3 | 23.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.3 | 38.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.3 | 52.7 | PID PLK1 PATHWAY | PLK1 signaling events |
1.2 | 37.4 | PID AURORA B PATHWAY | Aurora B signaling |
1.2 | 51.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.2 | 4.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.2 | 27.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.1 | 11.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.1 | 20.2 | PID ATM PATHWAY | ATM pathway |
1.1 | 34.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.0 | 14.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.0 | 2.9 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 18.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.9 | 7.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.9 | 1.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.9 | 31.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.9 | 6.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.9 | 24.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.8 | 21.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.8 | 24.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.8 | 34.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 1.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 4.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 28.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.7 | 5.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.7 | 12.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 17.5 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 1.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.6 | 9.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 22.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.6 | 21.2 | PID P73PATHWAY | p73 transcription factor network |
0.6 | 33.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 4.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 3.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 5.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.6 | 14.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 13.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 4.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 2.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 2.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.4 | 7.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 7.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 12.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.4 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 11.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 0.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 7.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 5.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 11.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.4 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 2.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.8 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 5.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 1.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 9.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 5.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 4.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 1.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 8.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 4.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 4.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 5.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 1.5 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 3.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 4.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 3.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 3.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.5 | 2.5 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
2.5 | 27.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
2.3 | 18.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
2.3 | 40.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
2.3 | 15.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
2.0 | 22.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.0 | 4.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
2.0 | 19.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.9 | 21.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.9 | 20.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.8 | 9.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.8 | 10.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.7 | 26.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
1.7 | 90.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.7 | 16.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
1.6 | 4.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.5 | 10.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.5 | 47.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
1.5 | 8.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.5 | 11.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
1.4 | 11.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.4 | 13.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.4 | 28.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.4 | 18.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.4 | 37.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.4 | 8.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.4 | 20.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.3 | 98.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.3 | 34.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.3 | 5.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.3 | 15.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.3 | 15.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 16.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.3 | 11.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.3 | 22.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.2 | 5.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.2 | 26.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.2 | 8.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.2 | 9.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.2 | 8.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.1 | 13.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.1 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.1 | 11.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.1 | 6.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.1 | 19.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.1 | 12.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.1 | 14.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.1 | 12.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 10.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.1 | 17.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.1 | 22.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.0 | 2.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.0 | 2.1 | REACTOME KINESINS | Genes involved in Kinesins |
1.0 | 5.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
1.0 | 11.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.0 | 3.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.0 | 21.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.0 | 44.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
1.0 | 9.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.0 | 2.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.0 | 19.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.0 | 35.1 | REACTOME TRANSLATION | Genes involved in Translation |
1.0 | 13.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
1.0 | 13.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.0 | 12.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
1.0 | 4.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.0 | 13.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.9 | 11.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.9 | 2.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.9 | 22.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.9 | 51.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.9 | 52.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.9 | 14.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 19.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.9 | 12.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.8 | 15.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.8 | 4.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.8 | 5.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.8 | 11.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.8 | 11.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 9.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.8 | 8.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.8 | 6.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.8 | 24.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.8 | 15.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.8 | 5.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.8 | 3.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.8 | 10.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.8 | 12.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.8 | 4.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 21.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.8 | 5.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 7.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.7 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.7 | 2.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.7 | 15.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 11.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.7 | 12.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 9.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.7 | 21.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.7 | 9.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.7 | 10.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 8.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 7.8 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.6 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 6.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 3.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 5.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 6.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.6 | 49.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.6 | 17.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 5.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.6 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.6 | 2.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 15.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.6 | 18.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 1.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.6 | 1.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 85.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 11.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 18.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 6.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.5 | 4.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 8.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 10.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.5 | 9.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 6.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.5 | 7.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 4.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 4.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 3.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 1.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 1.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 5.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 5.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 1.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 4.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 2.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 8.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 18.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 3.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 4.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.4 | 4.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 13.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.3 | 1.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 2.3 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.3 | 4.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 3.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 1.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 1.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 3.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 2.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 4.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 9.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 7.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 11.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 3.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 3.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 2.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 1.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 6.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 3.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 0.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.2 | 3.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 1.4 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 2.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.7 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 1.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.1 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |